Intelligence reports
The same data behind this site — packaged as sellable briefs. Every figure is traceable to the DRAP registry and observed retail sources as of 2026-07-30. Pilot pricing with reference pricing for the first partners per category.
- Molecule opportunity scoring & supply gaps
- Brand/company map with market structure
- Price room vs DRAP ceilings
- Regulatory & shortage exposure
- Brand footprint & molecule spread
- Top competitors by shared molecules
- Price band positioning across sources
- DRAP alert history
- Opportunity & competition score
- Who competes, who leads
- Price room & spread analysis
- Clinical positioning notes
What the data says right now
Highest-opportunity molecules from the live scoring. A category brief unpacks these into launch-ready analysis.
Published briefs
Three categories are already built from the same data behind this site. Open one to see the structure, depth and sourcing before you commission your own.
Insulins, sulfonylureas, DPP-4 and SGLT2 — competition, registration gaps and price positioning.
Open the Diabetes briefNSAIDs and analgesics — the most crowded category in Pakistan, and where the room still is.
Open the Pain & Inflammation briefAnti-infectives — essential-medicine coverage, crowding and regulatory exposure.
Open the Antibiotics briefWant one of these built for your company?
Category briefs and company profiles are the pilot package. First partner per category gets reference pricing. Tell us your category and we will send the relevant sample.
Request a brief WhatsApp us